Koppel Adam has filed 8 insider transactions across 3 companies since January 2024.
Most recent transaction: a grant/award of 38300 shares of Kailera Therapeutics, Inc. ($KLRA) on April 16, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | A | Stock Option (right to buy) | 38300 | $0.00 | 38,300.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | C | Series A-1 Preferred Stock | 16875000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | C | Series B Preferred Stock | 4145768 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | C | Common Stock | 16875000 | $0.00 | 16,875,000.0000 | 0 | 9999.99% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | C | Common Stock | 4145768 | $0.00 | 21,020,768.0000 | 0 | 24.57% | 0.00% |
| April 20, 2026 | Kailera Therapeutics, Inc. | $KLRA | Koppel Adam | Not found | P | Common Stock | 1562500 | $16.00 | 22,583,268.0000 | 0 | 7.43% | 0.00% |
| June 26, 2024 | Foghorn Therapeutics Inc. | $FHTX | Koppel Adam | Not found | A | Stock Options (Right to buy) | 16000 | $5.52 | 16,000.0000 | 41,974,484 | 9999.99% | 0.04% |
| Jan. 11, 2024 | Solid Biosciences Inc. | $SLDB | Koppel Adam | Not found | A | Common Stock | 904160 | $5.53 | 4,034,582.0000 | 19,884,007 | 28.88% | 4.55% |